Henwood Geraldine
SEC-identified person · CIK 1236451 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Baudax Bio, Inc. BXRX | Director · President and CEO | filed 2019 - 2022 |
| Societal Cdmo, Inc. SCTL | Director · President and CEO | filed 2014 - 2021 |
| Tetraphase Pharmaceuticals INC TTPH | Director | filed 2015 - 2019 |
| Alkermes plc. ALKS | Director | filed 2011 - 2014 |
| MAP Pharmaceuticals, Inc. MAPP | Director | filed 2007 - 2013 |
| Alkermes INC ALKS | Director | filed 2006 - 2011 |
| Auxilium Pharmaceuticals INC AUXL | Director · Chief Executive Officer | filed 2006 - 2006 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.